- Home
- ASRT vs NSPR Comparison
ASRT vs NSPR Comparison
Compare ASRT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- NSPR
- Stock Information
- Founded
- ASRT 1995
- NSPR 2005
- Country
- ASRT United States
- NSPR Israel
- Employees
- ASRT N/A
- NSPR N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- NSPR Medical/Dental Instruments
- Sector
- ASRT Health Care
- NSPR Health Care
- Exchange
- ASRT Nasdaq
- NSPR Nasdaq
- Market Cap
- ASRT 78.3M
- NSPR 63.0M
- IPO Year
- ASRT 1997
- NSPR N/A
- Fundamental
- Price
- ASRT $0.81
- NSPR $3.19
- Analyst Decision
- ASRT Strong Buy
- NSPR Strong Buy
- Analyst Count
- ASRT 4
- NSPR 2
- Target Price
- ASRT $3.19
- NSPR $4.75
- AVG Volume (30 Days)
- ASRT 320.8K
- NSPR 52.2K
- Earning Date
- ASRT 03-10-2025
- NSPR 03-05-2025
- Dividend Yield
- ASRT N/A
- NSPR N/A
- EPS Growth
- ASRT N/A
- NSPR N/A
- EPS
- ASRT N/A
- NSPR N/A
- Revenue
- ASRT $125,763,000.00
- NSPR $6,821,000.00
- Revenue This Year
- ASRT N/A
- NSPR $13.36
- Revenue Next Year
- ASRT $1.84
- NSPR $49.64
- P/E Ratio
- ASRT N/A
- NSPR N/A
- Revenue Growth
- ASRT N/A
- NSPR 24.70
- 52 Week Low
- ASRT $0.73
- NSPR $1.81
- 52 Week High
- ASRT $1.80
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- ASRT 45.61
- NSPR 63.51
- Support Level
- ASRT $0.78
- NSPR $2.60
- Resistance Level
- ASRT $0.88
- NSPR $3.11
- Average True Range (ATR)
- ASRT 0.03
- NSPR 0.28
- MACD
- ASRT 0.00
- NSPR 0.05
- Stochastic Oscillator
- ASRT 32.80
- NSPR 87.15
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.